Inmed Pharmaceuticals Inc. current report, 13 December 2022

Business Context and Reporting Period

This Form 8-K Current Report was filed by InMed Pharmaceuticals Inc. on December 13, 2022. The registrant is a British Columbia corporation with principal executive offices in Vancouver, Canada, and its common shares trade on The Nasdaq Stock Market LLC under the symbol "INM". The report addresses a material change regarding the company's independent registered public accounting firm and the upcoming Annual General Meeting (AGM).

Financial Metrics

This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance and auditor changes.

Material Changes

  • Auditor Resignation: KPMG LLP, the company's independent registered public accounting firm, declined to stand for reelection and resigned effective immediately on December 8, 2022. The audit committee accepted this resignation.
  • Proposed Auditor Appointment: The company intends to amend the auditor appointment resolution in its Management Information Circular to recommend the appointment of Marcum as the new independent registered public accounting firm.
  • Voting Authority: Management intends to rely on discretionary authority granted in previously distributed proxy forms to vote for the appointment of Marcum, unless shareholders revoke their proxies.

Guidance, Outlook, and Risks

The filing does not provide financial guidance, operational outlook, or specific risk factors beyond the immediate change in audit firm. The primary contingency noted is the requirement for shareholders who do not wish to vote for Marcum to revoke their proxies prior to the AGM. The company advises shareholders to consult professional advisors regarding the implications of the auditor change.

Key Facts for Investor Verification

  • Verify the reason for KPMG's resignation, as the filing states they "declined to stand for reelection" but does not elaborate on the underlying cause.
  • Confirm the timeline for the AGM and the specific date by which proxy revocations must be received (2:00 p.m. PST on the last business day preceding the meeting).
  • Review the full Management Information Circular (dated October 28, 2021) available on SEDAR to understand the original auditor proposal and other agenda items.
  • Monitor subsequent filings to confirm the formal appointment of Marcum and the transition of audit responsibilities.